Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Solutions Designed for Labs to Reduce Costs and Improve Productivity Showcased at the AACC Expo

By LabMedica International staff writers
Posted on 02 Aug 2013

Abbott (Abbott Park, IL, USA) features solutions to help labs prepare for the evolving healthcare environment. US healthcare providers are playing an increasingly important role in clinical labs to prevent medical errors, lower readmission rates, and improve patient care. Abbott showcased solutions designed to meet the needs of its lab customers while reducing costs and improving productivity at the American Association for Clinical Chemistry (AACC) annual meeting and clinical lab expo, July 28–August 1, 2013 in Houston (TX, USA).

Abbott also featured a variety of its solutions, including the first US Food and Drug Administration (FDA; Silver Spring, MD, USA)- approved genotyping test for hepatitis C (HCV), the RealTime HCV Genotype II test; the FDA-cleared FreeStyle Precision Pro Blood Glucose and β-Ketone Monitoring System; as well as the Accelerator a3600, a laboratory automation track system.

In addition, Abbott also showcased the company’s approach to customer-focused innovation through its program called "Factoring in the Human." On its recently launched Web site (please see Related Links below). Abbott shares the company’s focus on human factor principles and customer-centric approaches to influence product design. Laboratory professionals are encouraged to visit the website to learn more.

"Clinical laboratories are looking for the right solutions to successfully address the complexities and opportunities presented by the changing healthcare environment," said Greg Ahlberg, divisional vice president, US Commercial Operations, Diagnostics, Abbott. "Abbott has one of the broadest and most flexible portfolios available today to help labs drive efficiency and optimization, leading to improved patient care."

More than 30 scientific posters and/or oral presentations related to Abbott’s solutions will be presented during the AACC program. Seventeen posters cover cardiac markers and 13 focus on the performance of several clinical chemistry assays as well as on important areas, such as transplant, endocrine, metabolic, and congenitals.

Related Links:
Abbott
Abbott - Factoring the Human
US Food and Drug Administration